Optimization of cell therapy in patients with inflammatory bowel diseases

Optimization of cell therapy in patients with inflammatory bowel diseases

Aim. To elaborate optimal cell culture administration regimens to enhance the efficiency of anti-inflammatory therapy for inflammatory bowel diseases. Subjects and methods. Three groups of patients with chronic continuous or chronic recurrent ulcerative colitis (UC) were formed according to the trea...

Full description

Bibliographic Details
Main Authors:	L B Lazebnik, O V Kniazev, A I Parfenov, I N Ruchkina, P L Shcherbakov, S G Khomeriki, A G Konopliannikov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2012-08-01
Series:	Терапевтический архив
Subjects:	biological therapy inflammatory bowel diseases mesenchymal stromal cells
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31051

Similar Items

New possibilities for overcoming the secondary inefficiency of anti-cytokine therapy in patients with inflammatory bowel diseases
by: O V Kniazev, et al.
Published: (2013-02-01)

Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: Results of a 5-year follow-up
by: O V Kniazev, et al.
Published: (2015-02-01)

Value of adhesion molecules for evaluating the efficiency of therapy for ulcerative colitis and Crohn's disease
by: A I Parfenov, et al.
Published: (2014-02-01)

Combination biological therapy for fistular Crohn's disease: Clinical demonstration
by: O V Kniazev, et al.
Published: (2014-02-01)

Immune response to biological therapy for inflammatory bowel diseases
by: O V Kniazev, et al.
Published: (2013-12-01)

MSC therapy for inflammatory bowel disease
by: Mikhail A. Konoplyannikov, et al.
Published: (2021-03-01)

Bronchopulmonary lesions in chronic inflammatory bowel diseases
by: Zyfa Fyaskhetdinovna Mikhaylova, et al.
Published: (2010-03-01)

Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review
by: Jeffrey Zheng-Hsien Ko, et al.
Published: (2021-01-01)

Stem cells therapy in inflammatory bowel disease
by: Venera Rakhmetova, et al.
Published: (2017-12-01)

Use of mesenchymal stem cells in the combination therapy of ulcerative colitis
by: O V Knyazev, et al.
Published: (2016-02-01)

Clostridium difficile in inflammatory bowel disease
by: O V Knyazev, et al.
Published: (2018-11-01)

Modern therapy for inflammatory bowel disease
by: Novaković Aleksandra
Published: (2017-01-01)

Inflammatory Bowel Diseases: Focus on Therapy
by: Cristina Tocia, et al.
Published: (2018-02-01)

Systemic manifestations of inflammatory bowel diseases
by: A. I. Parfenov, et al.
Published: (2020-02-01)

Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases
by: Giuseppe Privitera, et al.
Published: (2021-02-01)

Management of infection in patients with inflammatory bowel disease
by: Sahil Khanna
Published: (2021-07-01)

Novel and Emerging Therapies for Inflammatory Bowel Disease
by: Badr Al-Bawardy, et al.
Published: (2021-04-01)

Psychological characteristics of patients with functional and inflammatory bowel disorders
by: Kozlova I.V., et al.
Published: (2014-03-01)

The Role of MicroRNAs upon Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease
by: Éva Boros, et al.
Published: (2019-11-01)

The Danish National Registry for Biological Therapy in Inflammatory Bowel Disease
by: Larsen L, et al.
Published: (2016-10-01)

Adherence to therapy of patients with inflammatory bowel diseases
by: A I Parfenov, et al.
Published: (2018-12-01)

Addressing pregnancy‐related concerns in women with inflammatory bowel disease: Insights from the patient's perspective
by: Emma K Flanagan, et al.
Published: (2021-01-01)

Biomarkers of inflammatory bowel disease activity
by: N A Fadeeva, et al.
Published: (2018-12-01)

Bowel Ultrasound in Inflammatory Bowel Disease: How Far in the Grayscale?
by: Federica Furfaro, et al.
Published: (2021-07-01)

Personalized medicine in the treatment of inflammatory bowel diseases
by: A I Parfenov, et al.
Published: (2018-02-01)

Diagnostic potential of endoscopic ultrasound for inflammatory bowel diseases and their complications
by: A. A. Budzinskaya, et al.
Published: (2021-05-01)

Prevalence of inflammatory bowel disease in the Chelyabinsk Region
by: A. I. Dolgushina, et al.
Published: (2019-12-01)

Angiogenesis and inflammatory bowel disease
by: Azzam Nahla
Published: (2007-01-01)

The cytokines in inflammatory bowel disease
by: Beata Polińska, et al.
Published: (2009-08-01)

Systemic Chemokine Levels with “Gut-Specific” Vedolizumab in Patients with Inflammatory Bowel Disease—A Pilot Study
by: Stephanie Zwicker, et al.
Published: (2017-08-01)

Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases
by: Atsunori Tsuchiya, et al.
Published: (2017-07-01)

Population-based cohort study on comparative effectiveness and safety of biologics in inflammatory bowel disease
by: Di Domenicantonio R, et al.
Published: (2018-02-01)

Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer
by: Fei Mao, et al.
Published: (2017-06-01)

INFLAMMATORY BOWEL DISEASE
by: I Gusti Ayu Mahaprani Danastri, et al.
Published: (2013-02-01)

Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
by: Akshay Kapoor, et al.
Published: (2021-05-01)

Mucosal Mast Cells in Irritable Bowel Syndrome and Inflammatory Bowel Disease
by: Bilge Tunc, et al.
Published: (2005-01-01)

Inflammatory bowel disease in the Chinese population.
Published: (2004)

Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms
by: Joanna Balding, et al.
Published: (2004-01-01)

Treatment of Anemia in Patients with Inflammatory Bowel Diseases
by: T.I. Boyko, et al.
Published: (2014-04-01)

Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease
by: Antigony Mitselou, et al.
Published: (2020-01-01)